Clinical Trial Update: A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update on the PET imaging agent 18F-AV-45 (florbetapir) studied in Alzheimer's disease patients and healthy volunteers; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• 18F-AV-45 (florbetapir)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED | Results posted: 2012-05-02